We are live on ! Find out more
VVM

Versant Venture Management Portfolio holdings

AUM $141M
1-Year Est. Return 190.82%
This Fund
S&P 500
This Quarter Est. Return
+36.78%
1 Year Est. Return
+190.82%
3 Year Est. Return
+375.7%
5 Year Est. Return
+81.85%
10 Year Est. Return
+4,735.29%
AUM
$171M
AUM Growth
-$3.46M
Cap. Flow
-$137K
Cap. Flow %
-0.08%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
GKOS icon
Glaukos
GKOS
+$137K

Sector Composition

Rank Sector Weight
1 Healthcare 93.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GKOS icon
1
Glaukos
GKOS
$8.89B
$77.6M 45.39%
3,136,232
-5,985
-0.2% -$137K
FPRX
2
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$45.3M 26.52%
1,092,152
– –
OCUL icon
3
Ocular Therapeutix
OCUL
$1.85B
$20.8M 12.15%
2,215,384
– –
CLVS
4
DELISTED
Clovis Oncology, Inc.
CLVS
$14.3M 8.34%
407,416
– –
AKAO
5
DELISTED
Achaogen Inc
AKAO
$7.35M 4.3%
1,281,152
– –
BITI
6
DELISTED
BIOTIE THERAPIES CORP SPONSORED ADR
BITI
$3.86M 2.26%
268,672
– –
CBAY
7
DELISTED
Cymabay Therapeutics
CBAY
$1.77M 1.04%
1,048,601
– –

Similar funds

POIA
Pin Oak Investment Advisors Houston, Texas $141M AUM 20.83% 1-Year Est. Return
MAM
Maytree Asset Management Hong Kong $141M AUM 114% 1-Year Est. Return
TM
TFJ Management Somerville, Massachusetts $141M AUM 9.28% 1-Year Est. Return
IA
IF Advisors San Antonio, Texas $141M AUM
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
RB
Renasant Bank Tupelo, Mississippi $141M AUM 16.9% 1-Year Est. Return
YEPX
Yorktown Energy Partners XI New York $142M AUM 130.51% 1-Year Est. Return
CFGW
Chancellor Financial Group WB Wilkes-Barre, Pennsylvania $141M AUM 23.22% 1-Year Est. Return

Versant Venture Management's Q4 2015 Portfolio in Review

As of Q4 2015, Versant Venture Management held 7 positions worth $171M, down 2% from $174M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2015: portfolio turnover was 0%. Versant Venture Management opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, down from 94% a quarter earlier.

  • Versant Venture Management's biggest Q4 2015 reduction was Glaukos, cutting an estimated $137K.
  • Versant Venture Management's ten largest holdings make up 100% of its $171M portfolio in Q4 2015.
  • Versant Venture Management opened 0 new positions and closed 0 in Q4 2015.
  • Versant Venture Management's portfolio value fell 2% quarter-over-quarter to $171M.

Based on Versant Venture Management's 13F filing for Q4 2015, filed 10 Feb 2016.